Fortress Biotech Inc expected to post a loss of 59 cents a share - Earnings Preview

Fortress Biotech

13/11/2024 15:52

* Fortress Biotech Inc  FBIO.OQ   FBIO.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
15 (estimated) for the period ending September 30 2024
    * The Bay Harbor Islands Florida-based  company is expected
to
report a 7.3% decrease in revenue to $32.218 million from $34.75
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Fortress Biotech Inc is
for a
loss of 59 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fortress
Biotech
Inc is $13.00​, above​ its last closing price of $1.70. ​​​

This summary was machine generated November 13 at 15:52 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)